Los antagonistas de los receptores H2 y la hipersensibilidad retardada.

Same author

Pioneers in dermatology and venereology: an interview with Prof. Malcolm Greaves.

Journal of the European Academy of Dermatology and Venereology : JEADV·2018

Same author

Cosmetics and toiletries: evaluation of efficacy, safety and quality.

Skin research and technology : official journal of International Society for Bioengineering and the Skin (ISBS) [and] International Society for Digital Imaging of Skin (ISDIS) [and] International Society for Skin Imaging (ISSI)·2016

Same author

Omalizumab for chronic spontaneous urticaria: a boon for sufferers, but there are unanswered questions.

The British journal of dermatology·2015

Same author

Chronic urticaria due to autoreactivity to progesterone.

Clinical and experimental dermatology·2015

Same author

Chronic urticaria: an orphan disease for 125 years.

The British journal of dermatology·2014

Same author

Unmet clinical needs in chronic spontaneous urticaria. A GA²LEN task force report.

Allergy·2010

Same journal

Assisted dying and the silencing of medicine's next generation.

Lancet (London, England)·2026

Same journal

Linguistic pragmatism: a woman with progressive abdominal pain in Thailand.

Lancet (London, England)·2026

Same journal

Medical compartmentalisation: a patient with chromosome 22q11.2 deletion syndrome in Japan.

Lancet (London, England)·2026

Same journal

[<sup>177</sup>Lu]Lu-edotreotide versus everolimus for gastroenteropancreatic neuroendocrine tumours (COMPETE): a phase 3, multicentre, randomised, open-label, superiority trial.

Lancet (London, England)·2026

Same journal

Research priorities for characterising Bundibugyo virus.

Lancet (London, England)·2026

Same journal

Rethinking treatment sequence in advanced gastroenteropancreatic neuroendocrine tumours.

Lancet (London, England)·2026

Videos de Experimentos Relacionados

Los antagonistas de los receptores H2 y la hipersensibilidad retardada.

Videos de Conceptos Relacionados

Pioneers in dermatology and venereology: an interview with Prof. Malcolm Greaves.

Cosmetics and toiletries: evaluation of efficacy, safety and quality.

Omalizumab for chronic spontaneous urticaria: a boon for sufferers, but there are unanswered questions.

Chronic urticaria due to autoreactivity to progesterone.

Chronic urticaria: an orphan disease for 125 years.

Unmet clinical needs in chronic spontaneous urticaria. A GA²LEN task force report.

Assisted dying and the silencing of medicine's next generation.

Linguistic pragmatism: a woman with progressive abdominal pain in Thailand.

Medical compartmentalisation: a patient with chromosome 22q11.2 deletion syndrome in Japan.

[<sup>177</sup>Lu]Lu-edotreotide versus everolimus for gastroenteropancreatic neuroendocrine tumours (COMPETE): a phase 3, multicentre, randomised, open-label, superiority trial.

Research priorities for characterising Bundibugyo virus.

Rethinking treatment sequence in advanced gastroenteropancreatic neuroendocrine tumours.

Videos de Experimentos Relacionados

Los antagonistas de los receptores H2 y la hipersensibilidad retardada.

Videos de Conceptos Relacionados

Artículos Relacionados

Pioneers in dermatology and venereology: an interview with Prof. Malcolm Greaves.

Cosmetics and toiletries: evaluation of efficacy, safety and quality.

Omalizumab for chronic spontaneous urticaria: a boon for sufferers, but there are unanswered questions.

Chronic urticaria due to autoreactivity to progesterone.

Chronic urticaria: an orphan disease for 125 years.

Unmet clinical needs in chronic spontaneous urticaria. A GA²LEN task force report.

Assisted dying and the silencing of medicine's next generation.

Linguistic pragmatism: a woman with progressive abdominal pain in Thailand.

Medical compartmentalisation: a patient with chromosome 22q11.2 deletion syndrome in Japan.

[<sup>177</sup>Lu]Lu-edotreotide versus everolimus for gastroenteropancreatic neuroendocrine tumours (COMPETE): a phase 3, multicentre, randomised, open-label, superiority trial.

Research priorities for characterising Bundibugyo virus.

Rethinking treatment sequence in advanced gastroenteropancreatic neuroendocrine tumours.